Table 2.
UTI (N = 14) | Colonized (N = 26) | p value | |
---|---|---|---|
Clinical and Laboratory Parameters | |||
Presence of fever, ≥37.9°C or hypothermia, <35.5°C (n, %) | 2 (15.4)a | 6 (27.3)c | 0.68 |
White cell count, ×109 per litre (median, IQR) | 8.9 (6.0–16.9)a | 9 (6.3–10.6)a | 0.67 |
Neutrophil count, ×109 per litre (median, IQR) | 6.1 (4.2–13.9)a | 6.2 (3.7–8.9)a | 0.37 |
CRP, mg/L (median, IQR) | 16.5 (8.0–88.8)b | 17 (7–63)d | 0.97 |
Polymicrobial growth in urine (n, %) | 4 (28.6) | 10 (38.5) | 0.73 |
Treatment e | |||
Antimicrobial treatment (n, %) | 11 (78.6) | 17 (68.0)a | 0.71 |
Intravenous only (n, %) | 2 (18.2) | 1 (5.9) | 0.54 |
Oral only (n, %) | 2 (18.2) | 12 (70.6) | 0.018 |
Both (n, %) | 7 (63.6) | 4 (23.5) | 0.052 |
Penicillin use (n, %) | 4 (36.4) | 11 (64.7) | 0.25 |
Other (n, %) | 11 (100.0) | 9 (52.9) | 0.010 |
Duration of treatment, days (median, IQR) | 9 (0.8–12) | 4 (0–11.5) | 0.21 |
Outcomes | |||
ICU admission (n, %) | 0 (0.0) | 2 (7.7) | 0.53 |
Mortality, 3 months (n, %) | 2 (20.0)c | 5 (20.8)b | 1.0 |
Complications (n, %) | 0 (0.0) | 1 (3.8) | 1.0 |
CRP: C-reactive protein, ICU: intensive care unit, IQR: interquartile range, UTI: urinary tract infection; Data was not available for a1, b2 c4 and d11 subjects; eTreatment was initiated in 11 subjects with UTI and 17 subjects with colonisation.